Sector ratings Vanda Pharmaceuticals Inc.
Equities
VNDA
US9216591084
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.390 USD | -14.11% |
|
-10.00% | -27.55% |
| May. 07 | Vanda Pharmaceuticals Inc., Q1 2026 Earnings Call, May 06, 2026 | |
| May. 06 | Vanda Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 384M | - | CCC | - | - | ||||
| 49.13B | A | |||||||
| 49.58B | AAA | |||||||
| 22.66B | - | A | - | - | ||||
| 23.52B | - | - | - | - | ||||
| 17.59B | AAA | |||||||
| 17B | A | |||||||
| 16.22B | B | |||||||
| 13.31B | - | - | - | - | ||||
| 13.55B | - | AA | - | - | ||||
| 12.33B | - | B | - | - | ||||
| 11.74B | BB | |||||||
| 10.92B | - | BB | - | - | ||||
| 9.24B | - | AA | - | - | ||||
| 9.45B | - | |||||||
| 9.01B | AA | - | ||||||
| 8.01B | - | CCC | - | - | ||||
| 7.43B | - | BBB | - | - | ||||
| 8.09B | - | CCC | - | - | ||||
| 8.19B | - | - | - | - | - | - | - | |
| Average | 15.87B | A | |||||||
| Weighted average by Cap. | A |
- Stock Market
- Equities
- VNDA Stock
- Sector Vanda Pharmaceuticals Inc.
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
